Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05181072 · ClinicalTrials.gov registry record · NA
Identify the Usefulness of In-person and Virtual Quit Smoking Programs
A NA study, sponsored by Morgan State University.
- Completed
- Registry status
- NA
- Development phase
- 392
- Enrollment target
NCT05181072: Completed NA study, sponsored by Morgan State University.
NCT05181072 is a NA study that has completed, run by Morgan State University. The registered enrollment target is 392 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05181072, a NA study, has completed, sponsored by Morgan State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 392 participants
- Enrollment target
Study Summary
This study is a randomized community-based trial adapted to the needs of adults aged 21 years or older that is designed by an existing research partnership called Communities Engaged and Advocating for Smoke-free Environments (CEASE). The overarching goal of the proposed study is to apply a community-based approach to reduce tobacco use among low-income communities in Baltimore City. The study setting represents three underserved communities in Baltimore City: the Oldtown/Middle East, the Waverlies, Poppleton/The Terraces/Hollins Market, and Washington Village/Pigtown. Poppleton/The Terraces/Hollins Market and Washington Village/Pigtown will be considered as one community. The three communities have been randomly allocated to one of the three arms of the study: 1) Virtual intervention, 2) Enhanced in-person intervention, and 3) The control community. The Waverlies was assigned to virtual, the Middle East was assigned to be the in-person group, and Poppleton/The Terraces/Hollins Market and Washington Village/Pigtown became the self-help/control group. The goal of the trial is to assess the effectiveness of virtual versus in-person versions of a smoking cessation program in terms of their success rates (quitting and staying quit). The study's primary hypothesis is that the smoking cessation rate will be equal to or higher in the virtual peer-motivation arm than the in-person and self-help/ control arms. The secondary hypothesis is that the retention rate will differ among the three interventions (virtual peer-motivation, enhanced in-person peer-motivation, and self-help/control community). Virtual and enhanced in-person versions of the CEASE Today Peer-Motivation Intervention were developed and pilot-tested during the first and second years based on local data and input from partnering communities. The enhanced in-person intervention will utilize the existing CEASE Today Tobacco Cessation Manual with improvements. The virtual intervention will use a newly developed
Primary Outcome
Self-reported smoking cessation verified by expired-air Carbon Monoxide (CO) levels. This will be measured using the CO breath monitor. Levels less than 8ppm will be considered as quit.
Interventions
- BEHAVIORAL Enhanced in-person peer-motivation smoking cessation
- BEHAVIORAL Virtual peer-motivation smoking cessation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 392 participants |
| Start Date | 2022-01-05 |
| Est. Completion | 2023-12-23 |
| Phase | NA |
What the finished NCT05181072 record still lists
NCT05181072 is an interventional study that assigns participants to a tested intervention. The registered 392 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower).
The record links to 0 conditions, and to 2 interventions - of which Enhanced in-person peer-motivation smoking cessation is the first listed.
NCT05181072 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05181072 about?
NCT05181072 is a clinical study titled "Identify the Usefulness of In-person and Virtual Quit Smoking Programs". This study is a randomized community-based trial adapted to the needs of adults aged 21 years or older that is designed by an existing research partnership called Communities Engaged and Advocating for Smoke-free Environments (CEASE). The overarching goal of the proposed study is to apply a communit...
What is the current status of trial NCT05181072?
This trial is currently completed. It is a NA study. The enrollment target is 392 participants. The study started on 2022-01-05. Estimated completion is 2023-12-23.
What interventions are being tested in trial NCT05181072?
The interventions under investigation include: Enhanced in-person peer-motivation smoking cessation (BEHAVIORAL), Virtual peer-motivation smoking cessation (BEHAVIORAL).
Who is sponsoring clinical trial NCT05181072?
This trial is sponsored by Morgan State University, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05181072's enrollment target sits among peer trials
392 269th of 2000 higher than 1,732 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06397703 · 392 participants · Phase 2
ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer
- NCT06625775 · 392 participants · Phase 1
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- NCT07220967 · 392 participants · Phase 4
A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement
- NCT07290036 · 392 participants · Phase 1
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI